203 related articles for article (PubMed ID: 28829357)
1. Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array.
Serio G; Pezzuto F; Marzullo A; Scattone A; Cavone D; Punzi A; Fortarezza F; Gentile M; Buonadonna AL; Barbareschi M; Vimercati L
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829357
[TBL] [Abstract][Full Text] [Related]
2. Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.
Chirac P; Maillet D; Leprêtre F; Isaac S; Glehen O; Figeac M; Villeneuve L; Péron J; Gibson F; Galateau-Sallé F; Gilly FN; Brevet M
Hum Pathol; 2016 Sep; 55():72-82. PubMed ID: 27184482
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
4. Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China.
Gao Z; Hiroshima K; Wu X; Zhang J; Shao D; Shao H; Yang H; Yusa T; Kiyokawa T; Kobayashi M; Shinohara Y; Røe OD; Zhang X; Morinaga K
Am J Ind Med; 2015 Oct; 58(10):1040-9. PubMed ID: 26147229
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal mesothelioma in Sweden: A population-based study.
Cashin PH; Jansson Palmer G; Asplund D; Graf W; Syk I
Cancer Med; 2019 Oct; 8(14):6468-6475. PubMed ID: 31483564
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
7. Malignant peritoneal mesothelioma.
Chun CP; Song LX; Zhang HP; Guo DD; Xu GX; Li Y; Xin X; Cao J; Li F
Am J Med Sci; 2023 Jan; 365(1):99-103. PubMed ID: 35940275
[TBL] [Abstract][Full Text] [Related]
8. Genomic changes of chromosomes 8p23.1 and 1q21: Novel mutations in malignant mesothelioma.
Serio G; Vimercati L; Pennella A; Gentile M; Cavone D; Buonadonna AL; Scattone A; Fortarezza F; De Palma A; Marzullo A
Lung Cancer; 2018 Dec; 126():106-111. PubMed ID: 30527173
[TBL] [Abstract][Full Text] [Related]
9. Asbestos-induced peritoneal mesothelioma in a construction worker.
Fonte R; Gambettino S; Melazzini M; Scelsi M; Zanon C; Candura SM
Environ Health Perspect; 2004 Apr; 112(5):616-9. PubMed ID: 15064170
[TBL] [Abstract][Full Text] [Related]
10. [A case of malignant peritoneal mesothelioma diagnosed by ascitic fluid aspiration with a 28-year history of asbestos exposure].
Nagata K; Sawai S; Kishida K; Watanabe Y; Suehiro I
Nihon Shokakibyo Gakkai Zasshi; 1990 Mar; 87(3):884-9. PubMed ID: 2201808
[No Abstract] [Full Text] [Related]
11. [Lung cancer and peritoneal mesothelioma: two complications of asbestos exposure in the same patient].
Amsalhem P; Kuhnle M; Bellamy J; Coblence JF; Leroy-Terquem E
Rev Pneumol Clin; 2005 Feb; 61(1 Pt 1):47-9. PubMed ID: 15772581
[TBL] [Abstract][Full Text] [Related]
12. Abdominal pain and bloating in an auto mechanic.
Neshatian L; Halland M; Arora AS
Gastroenterology; 2014 Jun; 146(7):1610-1. PubMed ID: 24755344
[No Abstract] [Full Text] [Related]
13. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
de Boer NL; van Kooten JP; Burger JWA; Verhoef C; Aerts JGJV; Madsen EVE
BMJ Open; 2019 May; 9(5):e026779. PubMed ID: 31092657
[TBL] [Abstract][Full Text] [Related]
14. Malignant peritoneal mesothelioma: quantitative analysis of asbestos burden.
Kurimoto R; Kishimoto T; Nagai Y; Takazawa H; Sakaue N; Shinohara Y; Hiroshima K
Pathol Int; 2009 Nov; 59(11):823-7. PubMed ID: 19883435
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.
Kaya H; Sezgı C; Tanrıkulu AC; Taylan M; Abakay O; Sen HS; Abakay A; Kucukoner M; Kapan M
Neoplasma; 2014; 61(4):433-8. PubMed ID: 24645844
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
17. Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review.
Jiang Y; Mei Z; Cao H; Li S; Xu H; Qiu H; Liu Y
Cancer Biol Ther; 2019; 20(12):1409-1415. PubMed ID: 31411522
[TBL] [Abstract][Full Text] [Related]
18. Malignant peritoneal mesothelioma. Case report and review of the literature.
Watteeuw G; D'Hondt A; Tannouri F; Recloux P; Hubert C
Acta Clin Belg; 1995; 50(4):222-6. PubMed ID: 7483973
[TBL] [Abstract][Full Text] [Related]
19. Diffuse malignant biphasic peritoneal mesothelioma with cystic areas.
Cabibi D; Tutino R; Salamone G; Cocorullo G; Agrusa A; Gulotta G
Ann Ital Chir; 2016 Jun; 87():. PubMed ID: 27320084
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.
Robella M; Vaira M; Mellano A; Marsanic P; Cinquegrana A; Borsano A; Barbera M; Caneparo A; Siatis D; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):9-15. PubMed ID: 24675242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
